Evidence map›Paper›PMID 36261283›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2022

The

Satoshi Yokoi, Takuji Ito, Kentaro Sahashi, Masahiro Nakatochi, Ryoichi Nakamura, Genki Tohnai, Yusuke Fujioka, Shinsuke Ishigaki, Tsuyoshi Udagawa, Yuishin Izumi and 9 more

Open access · hybridAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Neuronal TDP-43 regulates myelin formation via neurexin 1 mRNA stabilization.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Review
  6. Article
  7. The ALS-Related SynGAP1 Pathogenic Variant Causes Dendritic Spine Loss: Potential Mechanisms of Early-Stage ALS Progression.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 1 country.

Satoshi YokoiDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Takuji ItoDepartment of Neurology, Aichi Medical University School of Medicine, Aichi 480-1195, Japan.ORCID https://orcid.org/0000-0002-5078-0119
Kentaro SahashiDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Masahiro NakatochiPublic Health Informatics Unit, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya 461-8673, Japan.ORCID https://orcid.org/0000-0002-1838-4837
Ryoichi NakamuraDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Genki TohnaiDivision of ALS Research, Aichi Medical University, Aichi 480-1195, Japan.
Yusuke FujiokaDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Shinsuke IshigakiDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Tsuyoshi UdagawaGraduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.
Yuishin IzumiDepartment of Neurology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, Japan.
Mitsuya MoritaDivision of Neurology, Department of Internal Medicine, Jichi Medical University, Shimotsuke 329-0498, Japan.
Osamu KanoDepartment of Neurology, Toho University Faculty of Medicine, Tokyo 143-8540, Japan.
Masaya OdaDepartment of Neurology, Vihara Hananosato Hospital, Miyoshi 728-0001, Japan.
Takefumi SoneDepartment of Physiology, Keio University School of Medicine, Tokyo 160-0016, Japan.
Hideyuki OkanoDepartment of Physiology, Keio University School of Medicine, Tokyo 160-0016, Japan.ORCID https://orcid.org/0000-0001-7482-5935
Naoki AtsutaDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Masahisa KatsunoDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Yohei OkadaDepartment of Neurology, Aichi Medical University School of Medicine, Aichi 480-1195, Japan yohei@aichi-med-u.ac.jp sobueg@aichi-med-u.ac.jp.ORCID https://orcid.org/0000-0001-5253-8556
Gen SobueResearch Division of Dementia and Neurodegenerative Disease, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan yohei@aichi-med-u.ac.jp sobueg@aichi-med-u.ac.jp.
Aichi Medical University · JPNagoya University · JPKeio University · JPJichi Medical University · JPMiyoshi Kasei (Japan) · JPNagoya City University · JPToho University · JPTokushima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fused in sarcoma (FUS) is a pathogenic RNA-binding protein in amyotrophic lateral sclerosis (ALS). We previously reported that FUS stabilizes Synaptic Ras-GTPase activating protein 1 (

Indexed as

Amyotrophic Lateral SclerosisSarcoma3' Untranslated RegionsDendritic SpinesFemaleGTPase-Activating ProteinsHeterogeneous-Nuclear Ribonucleoprotein KHumansMaleMutationProtein Isoformsras GTPase-Activating ProteinsRNA-Binding Protein FUSRNA-Binding ProteinsRNA, Messenger3' Untranslated RegionsGTPase-Activating ProteinsHeterogeneous-Nuclear Ribonucleoprotein KHNRNPK protein, humanProtein Isoformsras GTPase-Activating ProteinsRNA-Binding Protein FUSRNA-Binding ProteinsRNA, MessengerSYNGAP1 protein, humanamyotrophic lateral sclerosisantisense oligonucleotidesdendritic spinehnRNPKiPSC-derived motor neuronSYNGAP1

Identifiers

PMID36261283
PMCPMC9698725
OpenAlexW4306818306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.